BioPorto

Research BioPorto (BIOPOR) on Bullrun: market cap DKK 631.26M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerBIOPOR
ExchangeCO
CountryDenmark
SectorHealthcare
IndustryDiagnostics & Research
CurrencyDKK
Market capDKK 631.26M
Financial periodFY2025
RevenueDKK 40.29M
Revenue growth11.2%
Net income-DKK 82.12M
Free cash flow-DKK 77.07M
Gross margin75.4%

Valuation Snapshot

latest market cap is DKK 631.26M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	DKK 40.29M	-DKK 82.12M	-DKK 77.07M	75.4%	n/a	DKK 54.89M	DKK 3.40M	DKK 63.01M
FY2024	DKK 36.24M	-DKK 68.24M	-DKK 83.93M	67.7%	n/a	DKK 59.66M	DKK 1.67M	DKK 67.75M
FY2023	DKK 30.96M	-DKK 56.33M	-DKK 55.50M	65.2%	-0.16	DKK 66.40M	DKK 2.59M	DKK 60.13M
FY2022	DKK 28.97M	-DKK 75.92M	-DKK 52.89M	65.7%	-0.24	DKK 81.79M	DKK 3.17M	DKK 70.22M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	DKK 631.26M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 DKK.

About BioPorto

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI);

Related stock research

Denmark stocks Denmark Healthcare stocks A-Z stock index

Other Healthcare stocks

Strategic Partners A/S (1TB0) 2cureX AB (2CUREX) CESSATECH A/S DK -20 (8GN) FLUOGUIDE A/S DK -1 (96X) ALK-Abelló A/S (ALK-B) Ambu A/S (AMBU-B) Ascendis Pharma A/S (ASND) Bavarian Nordic A/S (BV3A) Coloplast A/S (CBHD) ChemoMetec A/S (CHEMM) Demant A/S (DEMANT) Evaxion Biotech A/S (EVAX)

Frequently asked questions

What is BioPorto's market cap?

BioPorto's market capitalization is DKK 631.26M.